Skip to main content
. 2019 Aug 4;2019:1902817. doi: 10.1155/2019/1902817

Figure 2.

Figure 2

Improved nail psoriasis with onychomycosis and severe paronychia that persisted although the patient received nine months of canakinumab therapy.